Literature DB >> 15680351

Mouse hesr1 and hesr2 genes are redundantly required to mediate Notch signaling in the developing cardiovascular system.

Hiroki Kokubo1, Sachiko Miyagawa-Tomita, Makoto Nakazawa, Yumiko Saga, Randy L Johnson.   

Abstract

Notch signaling is required for multiple aspects of cardiovascular development, including arterial-venous differentiation, septation and cushion formation. Despite recognition of the importance of the Notch pathway in normal cardiovascular development, the proximate downstream effectors are not yet known. Likely candidate effectors are members of the hairy and enhancer of split related (hesr) family of bHLH transcription factors. However, mutational analysis of individual hesr genes has so far failed to elucidate their role in all Notch-mediated cardiovascular signaling events. An example of this is evident for mutants of gridlock, the zebrafish counterpart of mouse hesr2, which have vascular defects, whereas mouse hesr2 mutants have only cardiac defects. One possible explanation for these differences could be functional redundancy between hesr family members. Here, we report that mice lacking the hesr1 gene are viable and fertile, whereas knockout mouse of both hesr1 and hesr2 is embryonic lethal at 11.5 days postcoitum (dpc) and recapitulates most of the known cardiovascular phenotypes of disrupted Notch pathway mutants including defects in arterial-venous specification, septation and cushion formation. Taken together, our results demonstrate a requirement for hesr1 and hesr2 in mediating Notch signaling in the developing cardiac and vascular systems.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15680351     DOI: 10.1016/j.ydbio.2004.10.025

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  66 in total

1.  Integration of a Notch-dependent mesenchymal gene program and Bmp2-driven cell invasiveness regulates murine cardiac valve formation.

Authors:  Luis Luna-Zurita; Belén Prados; Joaquim Grego-Bessa; Guillermo Luxán; Gonzalo del Monte; Alberto Benguría; Ralf H Adams; José María Pérez-Pomares; José Luis de la Pompa
Journal:  J Clin Invest       Date:  2010-09-20       Impact factor: 14.808

Review 2.  Artery and vein formation: a tug of war between different forces.

Authors:  Fu-Jung Lin; Ming-Jer Tsai; Sophia Y Tsai
Journal:  EMBO Rep       Date:  2007-10       Impact factor: 8.807

3.  Hesr1 and Hesr2 may act as early effectors of Notch signaling in the developing cochlea.

Authors:  Toshinori Hayashi; Hiroki Kokubo; Byron H Hartman; Catherine A Ray; Thomas A Reh; Olivia Bermingham-McDonogh
Journal:  Dev Biol       Date:  2008-01-18       Impact factor: 3.582

4.  Drosophila Hey is a target of Notch in asymmetric divisions during embryonic and larval neurogenesis.

Authors:  Maria Monastirioti; Nikolaos Giagtzoglou; Konstantinos A Koumbanakis; Evanthia Zacharioudaki; Myrto Deligiannaki; Irmgard Wech; Mara Almeida; Anette Preiss; Sarah Bray; Christos Delidakis
Journal:  Development       Date:  2010-01       Impact factor: 6.868

Review 5.  Hey bHLH factors in cardiovascular development.

Authors:  Cornelia Wiese; Julia Heisig; Manfred Gessler
Journal:  Pediatr Cardiol       Date:  2009-12-24       Impact factor: 1.655

Review 6.  Endothelial cell plasticity: how to become and remain a lymphatic endothelial cell.

Authors:  Guillermo Oliver; R Sathish Srinivasan
Journal:  Development       Date:  2010-02       Impact factor: 6.868

7.  Ott1 (Rbm15) is essential for placental vascular branching morphogenesis and embryonic development of the heart and spleen.

Authors:  Glen D Raffel; Gerald C Chu; Jonathan L Jesneck; Dana E Cullen; Roderick T Bronson; Olivier A Bernard; D Gary Gilliland
Journal:  Mol Cell Biol       Date:  2008-11-03       Impact factor: 4.272

Review 8.  Signalling pathways that control vertebrate haematopoietic stem cell specification.

Authors:  Wilson K Clements; David Traver
Journal:  Nat Rev Immunol       Date:  2013-05       Impact factor: 53.106

Review 9.  Notch signaling in cardiac development and disease.

Authors:  José Luis de la Pompa
Journal:  Pediatr Cardiol       Date:  2009-01-31       Impact factor: 1.655

Review 10.  Choose your destiny: Make a cell fate decision with COUP-TFII.

Authors:  San-Pin Wu; Cheng-Tai Yu; Sophia Y Tsai; Ming-Jer Tsai
Journal:  J Steroid Biochem Mol Biol       Date:  2015-12-02       Impact factor: 4.292

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.